Genmab — August 2018
-
er realistisk. Jeg tror derfor også at den seneste tids fald skyldes denne usikkerhed/bekymring. Derfor ser jeg også et stort kurs potentiale (+15-20%)hvis Maia kommer ud til vores fordel med flotte
resultater. -
-
-
Glæder mig til at høre det

-
Så længe der ikke kommer mere ud af klinikken er de interviews ligegyldige
-
Hvilke hint?
-
Noget om genoptagelse / revision af protokollen?
-
Spørgsmål til Q&A er stadig meget velkommen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind